BPG is committed to discovery and dissemination of knowledge
Retrospective Study
Copyright: ©Author(s) 2026.
World J Gastroenterol. Dec 14, 2026; 32(46): 121360
Published online Dec 14, 2026. doi: 10.3748/wjg.121360
Table 1 Comparison of baseline clinical features and demographic characteristics between the neonatal intrahepatic cholestasis caused by citrin deficiency group and the control group
Parameter
Reference interval
NICCD group, n = 170
Control group, n = 196
T
P value
Age in months2.47 ± 1.261.98 ± 0.704.690.000
WBC (× 109)4.3-14.213.10 ± 4.1410.54 ± 3.146.720.000
N (× 109)0.6-7.54.10 ± 1.962.54 ± 1.319.020.000
L (× 109)2.4-9.57.57 ± 2.996.73 ± 2.413.000.003
HB (g/L)97-183100.20 ± 16.91104.4 ± 17.95-2.270.024
PLT (× 109)183-614 × 109501.40 ± 173.50420.50 ± 135.975.000.000
CRP (mg/L)0-52.29 ± 2.651.31 ± 1.774.210.000
TBIL (mol/L)3-20163.90 ± 65.47137.20 ± 87.323.280.001
DBIL (mol/L)1.7-6.878.82 ± 39.0591.66 ± 55.48-2.520.012
IBIL (mol/L)1.3-18.385.16 ± 45.7941.62 ± 31.7710.670.000
ALB (g/L)35-50 30.71 ± 4.6738.02 ± 3.27-17.510.000
GLO (g/L)9-2716.37 ± 4.0318.62 ± 9.03-2.9880.003
ALT (U/L)8-7163.18 ± 97.61187.00 ± 207.65-7.120.000
AST (U/L)21-80129.20 ± 115.20203.20 ± 182.28-4.560.000
ALT/AST2.60 ± 1.341.36 ± 0.7710.970.000
TBAC (mol/L)0.5-10180.80 ± 67.36125.40 ± 59.758.350.000
GGT (U/L)9-150186.10 ± 73.35198.40 ± 33.66-0.470.642
GLU (mmol/L)3.89-6.44.87 ± 8.944.66 ± 1.120.330.745
TG (mmol/L)0.33-1.821.65 ± 0.761.63 ± 0.720.270.789
TCHO (mmol/L)0-5.24.36 ± 1.324.12 ± 2.751.060.292
LACT (mmol/L)0.5-2.444.58 ± 1.653.69 ± 1.445.510.000
NH4 (mol/L)10-4776.53 ± 44.6951.54 ± 26.046.630.000
PT (seconds)10-1417.29 ± 8.4313.27 ± 2.876.270.000
APTT28-4849.42 ± 12.2643.54 ± 5.046.140.000
INR0.8-1.51.45 ± 1.211.00 ± 0.115.270.000
FIB (mg/dL)170-450135.00 ± 54.16288.80 ± 70.80-23.060.000


Write to the Help Desk